Connect with Leaders Advancing the Future of Immune Tolerance at World Immune Tolerance Week
The autoimmune disease landscape is driving growing interest in therapies capable of restoring immune tolerance without broad immunosuppression. As a result, antigen-specific immune tolerance has emerged as a closely watched areas of immunology, attracting increasing investment and innovation.
As therapies advance from discovery into clinical development, developers face growing challenges in demonstrating efficacy, defining biomarkers of tolerance, and navigating regulatory pathways. At the same time, securing the right scientific, service partners is critical to accelerating progress.
The 10th Antigen-Specific Immune Tolerance Summit returns to Boston as the industry's only dedicated forum focused exclusively on advancing antigen-specific immune tolerance therapies from discovery through clinical development. With clinical momentum building across the field and companies such as COUR Pharmaceuticals, Parvus Therapeutics, and Bonsai Therapeutics progressing programmes, this is a pivotal opportunity to connect with the organizations actively shaping the future of immune tolerance.
What to Expect?
Center Yourself Among Key Decision-Makers
Position your brand in front of the Scientific innovators driving the future of immune tolerance.
Meet New Clients
Expand your network and discover new business opportunities by connecting with established leaders and emerging players across the field.
Unlock High-Value Partnerships
Build meaningful relationships with biotech, pharma, investors and academic leaders to accelerate collaboration and drive mutual growth.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions the Autoimmune & Immunology Decision Makers Are Actively Searching For:
Our attendees from the Antigen-Specific Immune tolerance field are looking for service and solution providers with capabilities in the below areas but not limited to:
- Preclinical CROs
- Immunophenotyping
- Clinical CROs with disease relevant experience
- Cell Sequencing & Immune Profiling
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive dinners and tours to help elevate your brand.
Presenting Slots
Data-driven or case study-led presentations to position yourself as a thought-leader.
Leading Innovation
Expert panels to shape forward-thinking discussions.
Full Delegate List
Gain exclusive access to the Full Delegate List to plan your conversations in advance.
Exhibiting
Raise brand awareness and answer questions from prospect customers.
Networking
Engage in 1-2-1 conversations with industry or be part of the organized networking options to generate commercial collaborations.
Bespoke Hosting
Host breakfast, lunches, dinners for drinks receptions to have exclusive time with your target audience.
Champion the Industry
Be part of the autoimmune and immunology community and position yourself as an advocate for innovation and achievements in the immune tolerance space.
Branding
On-site and website branding to highlight your company at the forefront of the immune tolerance therapies in the autoimmune and immunology landscape.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Malik Mellal
Partnerships Director
Maintain Your Competitive Edge
Secure your position in a competitive market, ensuring your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with an audience of autoimmune and immunology experts during our dedicated networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship opportunities which include branding, presenting and exhibiting. Build a package tailored to you and your companies’ goals at the World Immune Tolerance week.